Document is current
Any future updates will be listed below
-
Authors
Rubin, Benjamin E. https://orcid.org/0000-0001-8684-2417
Diamond, Spencer https://orcid.org/0000-0003-4131-341X
Cress, Brady F. https://orcid.org/0000-0002-2948-2846
Crits-Christoph, Alexander
Lou, Yue Clare
Borges, Adair L. https://orcid.org/0000-0002-1477-7908
Shivram, Haridha
He, Christine https://orcid.org/0000-0002-7119-5509
Xu, Michael https://orcid.org/0000-0002-1801-2611
Zhou, Zeyi https://orcid.org/0000-0002-7548-9512
Smith, Sara J.
Rovinsky, Rachel
Smock, Dylan C. J.
Tang, Kimberly https://orcid.org/0000-0002-7718-2872
Owens, Trenton K.
Krishnappa, Netravathi
Sachdeva, Rohan https://orcid.org/0000-0001-9284-2245
Barrangou, Rodolphe https://orcid.org/0000-0002-0648-3504
Deutschbauer, Adam M. https://orcid.org/0000-0003-2728-7622
Banfield, Jillian F. https://orcid.org/0000-0001-8203-8771
Doudna, Jennifer A. https://orcid.org/0000-0001-9161-999X
- License Information
-
More Information
Article History
Received: 8 October 2021
Accepted: 29 October 2021
First Online: 6 December 2021
Competing interests
: The Regents of the University of California have patents pending related to this work on which B.E.R., S.D., B.F.C., A.M.D., J.F.B. and J.A.D. are inventors. J.A.D. is a cofounder of Caribou Biosciences, Editas Medicine, Scribe Therapeutics, Intellia Therapeutics and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Vertex, Caribou Biosciences, Intellia Therapeutics, eFFECTOR Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Synthego, Algen Biotechnologies, Felix Biosciences, The Column Group and Inari. J.A.D. is a Director at Johnson & Johnson and Tempus and has research projects sponsored by Biogen, Pfizer, AppleTree Partners and Roche. J.F.B. is a founder of Metagenomi. R.B. is a shareholder of Caribou Biosciences, Intellia Therapeutics, Locus Biosciences, Inari, TreeCo and Ancilia Biosciences. All other authors declare no competing interests.
